API Suppliers
US DMFs Filed
0
CEP/COS Certifications
0
JDMFs Filed
0
Other Certificates
0
Other Suppliers
0
0
USA (Orange Book)
0
Europe
0
Canada
0
Australia
0
South Africa
0
Uploaded Dossiers
0
U.S. Medicaid
0
Annual Reports
0
0
USFDA Orange Book Patents
0
USFDA Exclusivities
0
Blog #PharmaFlow
0
News
EDQM
0
USP
0
JP
0
Other Listed Suppliers
0
0
https://www.scoop.co.nz/stories/GE2109/S00183/researchers-present-key-research-results-on-diabetes-remission-of-dorzagliatin.htm
https://www.biospectrumasia.com/news/25/16551/hua-medicine-bayer-bring-novel-diabetes-treatment-in-china.html
https://www.acnnewswire.com/press-release/english/59982/hua-medicine-announces-positive-24-week-topline-results-of-phase-iii-metformin-combination-trial-of-dorzagliatin
https://www.globenewswire.com/news-release/2020/04/27/2022101/0/en/Hua-Medicine-Announces-Positive-Results-of-the-Combination-Study-of-Dorzagliatin-with-Empagliflozin-a-SGLT-2-inhibitor.html
https://endpts.com/arch-backed-chinese-biotech-scores-phiii-win-for-glucokinase-modulating-diabetes-drug/
https://endpts.com/hua-medicine-reaps-110-5m-adjusting-expectations-for-hong-kong-ipo/?utm_medium=email&utm_campaign=565%20Fri%2091418%20Allergan%20shells%20out%20195M-plus%20for%20a%20rival%20biotech%20Should%20Jos%20Baselga%20have%20been%20forced%20out%20at%20Memorial%20Sloan%20Kettering&utm_content=565%20Fri%2091418%20Allergan%20shells%20out%20195M-plus%20for%20a%20rival%20biotech%20Should%20Jos%20Baselga%20have%20been%20forced%20out%20at%20Memorial%20Sloan%20Kettering+CID_987373a0b5ef2e7493e004a13d237bc2&utm_source=ENDPOINTS%20emails&utm_term=Hua%20Medicine%20reaps%201105M%20adjusting%20expectations%20for%20Hong%20Kong%20IPO